missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Prostatic Acid Phosphatase/ACPP
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Brand: R&D Systems™ 6240-AP-010
265.22 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
Measured by its ability to cleave a substrate, p-Nitrophenyl phosphate (pNPP). The specific activity is >100,000 pmol/min/ug, as measured under the described conditions.Specifications
| P15309 | |
| Supplied as a 0.2 μm filtered solution in Tris and NaCl. | |
| M.W. (Observed): 43-55 kDa, reducing conditions; M.W. (theoretical): 41 kDa | |
| 10 μg | |
| Do not freeze. 3 months from date of receipt, 2°C to 8°C as supplied. 1 month, 2°C to 8°C under sterile conditions after opening. | |
| ACPP | |
| Recombinant | |
| Prostatic Acid Phosphatase/ACPP |
| Enzyme Activity | |
| 55 | |
| Prostatic Acid Phosphatase/ACPP | |
| Mouse myeloma cell line, NS0-derived human Prostatic Acid Phosphatase/ACPP protein Met1-Gln379, with a C-terminal 6-His tag | |
| <1.0 EU / 1 μg of the protein by the LAL method. | |
| Unconjugated | |
| >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain (at 5 μg / lane) |